logo

For the Inventor, By the Inventor

New York, NY, United States of America

Chdi Foundation, Inc.


USPTO Granted Patents = 56

% Expired Patents = 1.8



Forward Citations = 178

Loading Chart...
Loading Chart...

98 inventors (with patents filed for the assignee):

goldMedal Celia Dominguez (52 out of 80 patents)

silverMedal Michael Edward Prime (24 out of 25 patents)

bronzeMedal Peter David Johnson (19 out of 31 patents)

4.  Christopher John Brown (17 out of 26 patents)

5.  Leticia M Toledo-Sherman (17 out of 17 patents)

6.  John Wityak (16 out of 49 patents)

7.  Jonathan Bard (14 out of 14 patents)

8.  Christopher A Luckhurst (13 out of 13 patents)

9.  Alan Findlay Haughan (13 out of 29 patents)

10.  Daniel Clark-Frew (12 out of 12 patents)

11.  Perla Breccia (12 out of 12 patents)

12.  Andrew J Stott (12 out of 12 patents)

13.  William Mitchell (10 out of 10 patents)

14.  Roland W Bürli (10 out of 18 patents)

15.  Stephen Martin Courtney (9 out of 52 patents)


Core Competencies:
Isoindolinone Compounds
Huntingtin Protein
Antisense Oligonucleotides
Rho Kinase Inhibitors
HTT Modulators
Imaging Agents
Zinc Finger Proteins
Kynurenine-3-Monooxygenase Inhibitors
Histone Deacetylase Inhibitors
Heterocyclic Compounds
Transglutaminase TG2 Inhibitors
Probes for Imaging

56 patents:

1. 12661415 - Isoindolinone compounds and imaging agents for imaging Huntingtin protein (2026-06-23),
2. 12551580 - Heterocyclic compounds and imaging agents for imaging Huntington protein (2026-02-17),
3. 12509681 - Antisense oligonucleotides directed to huntingtin (2025-12-30),
4. 12428413 - Rho kinase inhibitors and compositions and methods of use thereof (2025-09-30),
5. 12281116 - HTT modulators for treating Huntington's disease (2025-04-21),
6. 12258355 - Probes for imaging huntingtin protein (2025-03-25),
7. 12083108 - Compounds for targeting mutant huntingtin protein and uses thereof (2024-09-10),
8. 12036292 - Heterobiaryl compounds and imaging agents for imaging huntingtin protein (2024-07-16),
9. 12036291 - Probes for imaging huntingtin protein (2024-07-16),
10. 11992535 - Compounds and probes for imaging huntingtin protein (2024-05-28),
11. 11918662 - Heterocyclic compounds and imaging agents for imaging huntingtin protein (2024-03-05),
12. 11851446 - Probes for imaging Huntingtin protein (2023-12-26),
13. 11806346 - HTT modulators for treating Huntington's disease (2023-11-07),
14. 11685734 - ATM kinase inhibitors and compositions and methods of use thereof (2023-06-27),
15. 11421007 - Zinc finger protein compositions for modulation of huntingtin (Htt) (2022-08-23),
Chdi Foundation, Inc. is a non-profit organization based in New York, dedicated to advancing research and development for Huntington's disease. The foundation focuses on innovative therapeutic approaches, including isoindolinone compounds, antisense oligonucleotides, and Rho kinase inhibitors, to target the underlying mechanisms of the disease. By leveraging cutting-edge technologies such as imaging agents and HTT modulators, Chdi aims to facilitate the discovery of effective treatments and improve the quality of life for those affected by Huntington's disease.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Chdi Foundation, Inc.
56 Patents

#173 in New York, NY

#386 in New York

#6,346 in US

#12,732 in the World

New York, NY (US)
New York, NY, United States of America

Chdi Foundation, Inc.

Forward Citations = 178

98 inventors:

goldMedal Celia Dominguez (52 out of 80 patents)

silverMedal Michael Edward Prime (24 out of 25 patents)

bronzeMedal Peter David Johnson (19 out of 31 patents)

4.  Christopher John Brown (17 out of 26 patents)

5.  Leticia M Toledo-Sherman (17 out of 17 patents)

Please report any incorrect information to [email protected]
Loading…